acetylcysteine has been researched along with 9-deoxy-delta-9-prostaglandin d2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cisowski, J; Dulak, J; Huk, I; Józkowicz, A; Nigisch, A; Weigel, G | 1 |
| Blumberg, N; Francis, CW; Gertz, JM; O'Brien, JJ; Palis, J; Phipps, RP; Seweryniak, KE; Spinelli, SL; Taubman, MB; Tober, J | 1 |
2 other study(ies) available for acetylcysteine and 9-deoxy-delta-9-prostaglandin d2
| Article | Year |
|---|---|
Prostaglandin-J(2) upregulates expression of matrix metalloproteinase-1 independently of activation of peroxisome proliferator-activated receptor-gamma.
Topics: Acetylcysteine; Cells, Cultured; Endothelial Cells; Humans; Matrix Metalloproteinase 1; Neovascularization, Physiologic; Oxidative Stress; Prostaglandin D2; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Transcription Factors; Up-Regulation | 2003 |
15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Blood Platelets; Bone Marrow; Cell Line; Female; Glutathione; Humans; Male; Megakaryocytes; Mice; Platelet Transfusion; PPAR gamma; Prostaglandin D2; Radiation Injuries, Experimental; Reactive Oxygen Species; Thrombocytopenia | 2008 |